According to Innoviva's latest financial reports the company's total liabilities are $0.56 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.66 B | 66.24% |
2021-12-31 | $0.40 B | 2.23% |
2020-12-31 | $0.39 B | 2.36% |
2019-12-31 | $0.38 B | -1.65% |
2018-12-31 | $0.38 B | -36.21% |
2017-12-31 | $0.61 B | -16.66% |
2016-12-31 | $0.73 B | -4.53% |
2015-12-31 | $0.76 B | 2.91% |
2014-12-31 | $0.74 B | 94.96% |
2013-12-31 | $0.38 B | 78.94% |
2012-12-31 | $0.21 B | -38.25% |
2011-12-31 | $0.34 B | -2.2% |
2010-12-31 | $0.35 B | -4.53% |
2009-12-31 | $0.37 B | -0.19% |
2008-12-31 | $0.37 B | 62.59% |
2007-12-31 | $0.22 B | 14.63% |
2006-12-31 | $0.19 B | 20.49% |
2005-12-31 | $0.16 B | 72.76% |
2004-12-31 | $95.65 M | -77.49% |
2003-12-31 | $0.42 B | 0.09% |
2002-12-31 | $0.42 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | $0.62 B | 10.72% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $11.57 M | -97.95% | ๐บ๐ธ USA |